Tradestie Institutional Equity Comparison Engine

SNY vs MAIA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SNY Overall Edge

SNY Captures Institutional Edge (2โ€“2 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) driven by superior Growth & Margin, Options & Structure while MAIA counters with relative strength in Valuation, Momentum & Technical. Fundamentally, SNY trades at 8.6x Forward P/E with 22.3% operating margin (+15.7% YoY revenue) versus MAIA at 1.2x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SNY sits in UNCLASSIFIED (43rd %ile IV; Dealer Gamma Walls on Pro) against MAIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner MAIA
SNY 8.6x vs MAIA 1.2x Fwd P/E
Growth & Margin Winner SNY
Op Margin 22.3% vs 0.0% ยท YoY +15.7% vs +0.0%
Momentum & Technical Winner MAIA
1Y -6.1% vs +20.6% ยท 52W Pos 65% vs 10%
Options & Structure Winner SNY
UNCLASSIFIED (43rd %ile IV) vs UNCLASSIFIED (N/A IV)
SNY NASDAQ
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Pharmaceutical Preparations
$46.52
+1.0% 1D
Market Cap $110.6B
1M Return +10.87%
1Y Return -6.12%
Forward P/E 8.6x
Unified AI Score
40.3 / 100 SELL
Tech 32.0 Fund 43.0 Flow 50.0 Mom 50.0
MAIA NYSE American
MAIA Biotechnology, Inc.
Pharmaceutical Preparations
$1.11
-2.63% 1D
Market Cap $68.5M
1M Return -1.77%
1Y Return +20.65%
Forward P/E 1.2x
Unified AI Score
37.6 / 100 SELL
Tech 40.0 Fund 38.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SNY -6.12% MAIA +20.65% Spread: +26.77 pp (MAIA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SNY TTM Op. Margin: 22.3% MAIA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SNY vs MAIA. Trailing 12-month operating profitability (SNY 22.3% vs MAIA 0.0%) and valuation multiples (SNY 8.6x vs MAIA 1.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SNY (8) vs MAIA (2)
Institutional Metric SNY MAIA Criterion Row Winner
Market Capitalization Scale $110.6B $68.5M Larger Scale SNY
Trailing P/E Ratio Valuation 22.9x 1.2x Lower Multiple MAIA
Forward P/E Ratio Valuation 8.6x 1.2x Lower Multiple MAIA
Revenue Growth (YoY) Growth +15.7% +0.0% Higher Growth SNY
Operating Margin (TTM) Profitability 22.3% 0.0% Higher Margin SNY
Net Profit Margin Profitability 8.2% 0.0% Higher Margin SNY
Return on Equity (ROE) Capital Efficiency 5.7% -341.5% Higher ROE SNY
52-Week Range Position Momentum 65% ($39โ€“$51) 10% ($1โ€“$3) Stronger Trend SNY
Beta / 30D Volatility Risk Regime 0.20ฮฒ ยท 26% Vol 1.65ฮฒ ยท 108% Vol Lower Realized Risk SNY
Unified Institutional Score Composite Signal 40.3 / 100 (SELL) 37.6 / 100 (SELL) Higher Composite SNY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SNY vs MAIA Buy Guide
SNY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 43rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live SNY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MAIA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MAIA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SNY nor MAIA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.